"I'm a bit fan of cheap biotechs that are about to launch products, but I need to be confident of success first."
These are mutually exclusive terms in the biotech world...by its very nature, you cannot be confident of success when biotechs launch...it's a risk you are either willing to take, or not
Ironically, the Oraline series is not a launch...it's a re-launch. It was highly regarded when it first launched and failed due what was, IMO and that of others, the monumental indifference of the Board at the time and the actions of it's American CEO
Add to My Watchlist
What is My Watchlist?